Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
Public ClinicalTrials.gov record NCT00080314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate flexible doses (5-30mg) of aripiprazole versus placebo in patients with bipolar depression.
Study identification
- NCT ID
- NCT00080314
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2004 (Type not available)
- Primary completion
- Oct 2006 (Actual)
- Completion
- Oct 2006 (Actual)
- Last update posted
- Nov 11, 2013
2004 – 2006
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Tuscaloosa | Alabama | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Sherman Oaks | California | — | — |
| Local Institution | Norwich | Connecticut | — | — |
| Local Institution | West Haven | Connecticut | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Maitland | Florida | — | — |
| Local Institution | Orlando | Florida | — | — |
| Local Insstitution | Honolulu | Hawaii | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Lake Charles | Louisiana | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Durham | North Carolina | — | — |
| Local Institution | Raleigh | North Carolina | — | — |
| Local Institution | Beachwood | Ohio | — | — |
| Local Institution | Dayton | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Media | Pennsylvania | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Lake Jackson | Texas | — | — |
| Local Institution | Wichita Falls | Texas | — | — |
| Local Institution | Arlington | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00080314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00080314 live on ClinicalTrials.gov.